Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|8|1063-1076

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.8, 2015-08, pp. : 1063-1076

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance

By  

EMBO Molecular Medicine, Vol. 7, Iss. 6, 2015-06 ,pp. : 735-753

John Wiley & Sons Inc

Access to resources Recommend Favorite

Distinct MR Imaging Features of Triple‐Negative Breast Cancer with Brain Metastasis

By  

Journal of Neuroimaging, Vol. 25, Iss. 3, 2015-05 ,pp. : 474-481

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer‐specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells

By  

Molecular Carcinogenesis, Vol. 54, Iss. 12, 2015-12 ,pp. : 1529-1540

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules

By  

Molecular Carcinogenesis, Vol. 54, Iss. 7, 2015-07 ,pp. : 554-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduced retinoids and retinoid receptors' expression in pancreatic cancer: A link to patient survival

By  

Molecular Carcinogenesis, Vol. 54, Iss. 9, 2015-09 ,pp. : 870-879

John Wiley & Sons Inc

Access to resources Recommend Favorite